Trial
NCT05254405
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Donald Jeffrey Newport
Collaborators
Sage Therapeutics
Condition
Post-Traumatic Stress Disorder
Intervention
Brexanolone Injection [Zulresso]
Why stopped
Loss of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22